This inventor holds 1 USPTO granted patent. Top assignee: Arexis Ab. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: The Innovations of Patrick Chardon
Introduction
Patrick Chardon is a notable inventor based in Vauhallan, France. He has made significant contributions to the field of biotechnology, particularly in the area of energy metabolism. His work has implications for the diagnosis and treatment of various metabolic dysfunctions.
Latest Patents
Patrick Chardon holds a patent for "Variants of the Gamma Chain of AMPX, DNA sequences encoding the same, and uses thereof." This patent focuses on the variants of the gamma chain of vertebrate AMP-activated kinase (AMPK), as well as nucleic acid sequences encoding these variants. The applications of this invention are crucial for diagnosing or treating dysfunctions related to energy metabolism. He has 1 patent to his name.
Career Highlights
Chardon is associated with Arexis AB, a company that specializes in innovative biotechnological solutions. His work at Arexis AB has allowed him to explore and develop groundbreaking research in the field of metabolic disorders.
Collaborations
Throughout his career, Patrick has collaborated with esteemed colleagues such as Ernst Kalm and Nathalie Iannuccelli. These collaborations have enriched his research and contributed to the advancement of their shared goals in biotechnology.
Conclusion
Patrick Chardon is a distinguished inventor whose work in biotechnology has the potential to impact the treatment of energy metabolism disorders. His innovative patent and collaborations highlight his commitment to advancing scientific knowledge and improving health outcomes.